On March 30, 2026, Selectis Health, Inc. (the "Company") reported the resignation of David Furstenberg from its Board of Directors and Audit Committee, effective immediately. The Company expressed gratitude for Mr. Furstenberg's service and support during his tenure. This change in leadership may have implications for the Company's governance and strategic direction, but it is not expected to have a significant immediate impact on the stock price. The Company continues to operate under its existing strategies and governance structures, and no immediate replacement for Mr. Furstenberg has been announced. The resignation falls under Item 5.02 of Form 8-K, which pertains to the departure of executive officers and directors. As Selectis Health navigates this transition, stakeholders will be watching closely for any further developments regarding leadership changes and their potential effects on the Company's operations and strategic initiatives.

Press Release distribution

National Press Distribution across U.S. Media. Direct Access to Key Decision Making Editors.